Company / PP&E per Share
West Pharmaceutical Services PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$23.88
FY2025
5-year range
$14.29 / $23.88
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
#14 of 130
Health Care
What the data says
West Pharmaceutical Services's pp&e per share of $23.88 is higher than 89% of companies in the Health Care sector (FY2025). PP&E per Share has increased for 7 consecutive years, from $11.12 in FY2018 to $23.88 in FY2025.
Based on SEC 10-K filings.
23.88 in FY2025 with a 5-year CAGR of +13.4%. Top quartile in the Health Care sector.
Improved from $19.07 to $23.88 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- +13.4%
- 10-Year CAGR
- -
Sector benchmark
+102.4% above sector average
Key checks
Key Insights
- West Pharmaceutical Services's pp&e per share has grown for 7 consecutive years.
- In FY2025, pp&e per share increased 11.0% year-over-year.
- Ranks #14 out of 130 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.88 | +11.0% |
| FY2024 | $21.52 | +12.8% |
| FY2023 | $19.07 | +22.2% |
| FY2022 | $15.61 | +9.2% |
| FY2021 | $14.29 | +12.3% |
| FY2020 | $12.73 | +12.4% |
| FY2019 | $11.33 | +1.8% |
| FY2018 | $11.12 | -4.9% |
| FY2017 | $11.70 | +17.3% |
| FY2016 | $9.97 | +0.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026